These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 22088139)
21. Compatibility of chewing gum excipients with the amino acid L-cysteine and stability of the active substance in directly compressed chewing gum formulation. Kartal A; Björkqvist M; Lehto VP; Juppo AM; Marvola M; Sivén M J Pharm Pharmacol; 2008 Sep; 60(9):1131-8. PubMed ID: 18718115 [TBL] [Abstract][Full Text] [Related]
22. Salt-assisted liquid-liquid microextraction with water-miscible organic solvents for the determination of carbonyl compounds by high-performance liquid chromatography. Gupta M; Jain A; Verma KK Talanta; 2009 Dec; 80(2):526-31. PubMed ID: 19836515 [TBL] [Abstract][Full Text] [Related]
23. Characterization of degradation products of amorphous and polymorphic forms of clopidogrel bisulphate under solid state stress conditions. Raijada DK; Prasad B; Paudel A; Shah RP; Singh S J Pharm Biomed Anal; 2010 Jul; 52(3):332-44. PubMed ID: 19520540 [TBL] [Abstract][Full Text] [Related]
24. Trends in active pharmaceutical ingredient salt selection based on analysis of the Orange Book database. Paulekuhn GS; Dressman JB; Saal C J Med Chem; 2007 Dec; 50(26):6665-72. PubMed ID: 18052022 [TBL] [Abstract][Full Text] [Related]
25. Implementing quality by design in pharmaceutical salt selection: a modeling approach to understanding disproportionation. Merritt JM; Viswanath SK; Stephenson GA Pharm Res; 2013 Jan; 30(1):203-17. PubMed ID: 22918819 [TBL] [Abstract][Full Text] [Related]
27. Stress degradation studies on lornoxicam using LC, LC-MS/TOF and LC-MSn. Modhave DT; Handa T; Shah RP; Singh S J Pharm Biomed Anal; 2011 Nov; 56(3):538-45. PubMed ID: 21757313 [TBL] [Abstract][Full Text] [Related]
28. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method. Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610 [TBL] [Abstract][Full Text] [Related]
29. A high-temperature liquid chromatographic reactor approach for investigating the solvolytic stability of a pharmaceutical compound and an investigation of its retention behavior on a C18-modified zirconia stationary phase. Skrdla PJ; Bopra A; Chasse T; Wang T J Pharm Biomed Anal; 2008 Jun; 47(2):312-9. PubMed ID: 18295428 [TBL] [Abstract][Full Text] [Related]
30. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities. Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517 [TBL] [Abstract][Full Text] [Related]
31. Salt disproportionation: A material science perspective. Thakral NK; Kelly RC Int J Pharm; 2017 Mar; 520(1-2):228-240. PubMed ID: 28163222 [TBL] [Abstract][Full Text] [Related]
32. Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy. Verbeeck RK; Kanfer I; Walker RB Eur J Pharm Sci; 2006 May; 28(1-2):1-6. PubMed ID: 16413762 [TBL] [Abstract][Full Text] [Related]
33. X-ray powder diffractometry of intact film coated tablets--an approach to monitor the physical form of the active pharmaceutical ingredient during processing and storage. Yamada H; Suryanarayanan R J Pharm Sci; 2007 Aug; 96(8):2029-36. PubMed ID: 17541977 [TBL] [Abstract][Full Text] [Related]
34. LC-MS characterization of trace impurities contained in calcium folinate. Francese G; Corana F; Meneghetti O; Marazza F J Pharm Biomed Anal; 2005 Sep; 39(3-4):757-63. PubMed ID: 15927438 [TBL] [Abstract][Full Text] [Related]
35. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form. Wu Y; Dali M; Gupta A; Raghavan K Pharm Dev Technol; 2009; 14(5):556-64. PubMed ID: 19743950 [TBL] [Abstract][Full Text] [Related]
37. Development and validation of an LC-UV method for the quantification and purity determination of the novel anticancer agent C1311 and its pharmaceutical dosage form. den Brok MW; Nuijen B; Hillebrand MJ; Grieshaber CK; Harvey MD; Beijnen JH J Pharm Biomed Anal; 2005 Sep; 39(1-2):46-53. PubMed ID: 15899571 [TBL] [Abstract][Full Text] [Related]
38. Stability studies of ionised and non-ionised 3,4-diaminopyridine: hypothesis of degradation pathways and chemical structure of degradation products. Raust JA; Goulay-Dufaÿ S; Le Hoang MD; Pradeau D; Guyon F; Do B J Pharm Biomed Anal; 2007 Jan; 43(1):83-8. PubMed ID: 16844337 [TBL] [Abstract][Full Text] [Related]
39. A novel approach for analyzing glass-transition temperature vs. composition patterns: application to pharmaceutical compound+polymer systems. Kalogeras IM Eur J Pharm Sci; 2011 Apr; 42(5):470-83. PubMed ID: 21324354 [TBL] [Abstract][Full Text] [Related]
40. The Effect of In-Situ-Generated Moisture on Disproportionation of Pharmaceutical Salt. Weldeab AO; McElderry JD; Lin Y Mol Pharm; 2023 Jan; 20(1):561-571. PubMed ID: 36524757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]